Diagnostic investigation of patients with chronic polyneuropathy: evaluation of a clinical guideline.
نویسندگان
چکیده
OBJECTIVE (1) To evaluate a clinical guideline for the diagnostic investigation of patients presenting with signs and symptoms (present for longer than 6 weeks) suggesting a chronic polyneuropathy. (2) To investigate the contribution of electrophysiological studies to a focused search for aetiology in these patients. METHODS A chart review was carried out of a consecutive group of outpatients in 1993-7 at a university department of neurology, with signs and symptoms suggesting a polyneuropathy in whom the diagnostic investigation had been carried out according to a recently introduced guideline. Diagnostic tests were performed and final diagnoses were made. RESULTS Unnecessary investigations were carried out in 108 (51%) of 213 patients and too few tests in 23 (11%) of these patients. In 82 (48%) of the 172 patients who fulfilled the inclusion criteria neurophysiological tests did not contribute to the final diagnosis. Neurophysiological criteria for demyelination were fulfilled in only 13 (8%) of the 172 patients. CONCLUSION In patients presenting with signs and symptoms of chronic polyneuropathy the number of tests in the diagnostic investigation can be considerably reduced. In patients with signs and symptoms of polyneuropathy, providing the clinical phenotype is typical, in the presence of diabetes mellitus, renal failure, HIV infection, alcoholism, or use of potentially neurotoxic drugs further investigations are non-contributory. The significance of electrophysiological studies in the investigation of patients with polyneuropathy is rather to separate sensorimotor neuropathies from pure sensory neuropathies than to distinguish between demyelinating and axonal neuropathies.
منابع مشابه
A case of chronic inflammatory demyelinating polyneuropathy presented with unilateral ptosis
Chronic Inflammatory Demyelinating Polyneuropathy is an autoimmune disease with progressive and relapsing courses. The main clinical presentations are diffuse deep tendon hyporeflexia or areflexia and symmetric proximal-distal muscles weakness. Myasthenia gravis is also an immune mediated disease with fluctuating ocular and bulbar symptoms and sometimes weakness. Although both myasthenia grav...
متن کاملInvestigation of the prevalence of underlying diseases in Covid-19 patients in Yasuj
Introduction: Acute respiratory disease caused by the new coronavirus (COVID-19), which was identified in December 2019, is rapidly evolving in the world and has been identified by the World Health Organization as a major global threat. Objective: The aim of this study was to investigate the relation between the underlying diseases in Covid-19 patients and the severity of their symptoms and hen...
متن کاملبررسی و شمارش ائوزینوفیل های خون محیطی و مخاط بینی در بیماران مبتلا به رینوسینوزیت مزمن
Background and purpose: Chronic rhinosinusitis is a worldwide health concern with almost unknown etiology. In the current investigation, we explored the relation of nasal mucosal and systemic eosinophilia with chronic inflammation to elucidate the role of eosinophils in chronic rhinosinusitis. Materials and methods: The study population included 50 patients with chronic rhinosinusitis. Samples...
متن کاملUndifferentiated arthritis: predictive factors of persistent arthritis and treatment decisions
A number of patients with inflammatory arthritis due to inadequate clinical or laboratory data do not fulfill diagnostic criteria for a clinical disease categories. These patients with initial diagnosis of undifferentiated arthritis (UA) may remit or progress to a definite well- defined condition such as rheumatoid arthritis (RA) or remain as UA with persistence of inflammatory arthritis. The m...
متن کاملO20: NK Cells as Surrogate Marker for Predicting Treatment Efficacy in Chronic Inflammatory Demyelinating Polyneuropathy
Natural Killer (NK) cells are part of our innate immune system with regulatory and effector functions. Different studies suggest that treatment with intravenous immunoglobulins (IVIg) has an immunomodulatory effect on NK cells. IVIg is a first-line treatment for various autoimmune diseases in particular in chronic inflammatory demyelinating polyneuropathy (CIDP). The lack of predictive markers ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Journal of neurology, neurosurgery, and psychiatry
دوره 71 2 شماره
صفحات -
تاریخ انتشار 2001